Oncology
Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins
May 18, 2023Research and Development Aitia, Digital Twins, Oncology, Pancreatic cancer, Servier
French pharmaceutical company Servier and US-based Causal AI and Digital Twins company Aitia have announced a collaboration to create Digital …
Asieris Pharmaceuticals and Uroviu announce strategic collaboration to further develop integrated diagnosis and treatment for bladder cancer
May 18, 2023Research and Development Asieris Pharmaceuticals, Diagnostics, Oncology, Uroviu, bladder cancer, oncology
US-based biopharmaceutical company Asieris Pharmaceuticals and single-use endoscopic platform creator Uroviu have announced that they have entered into a strategic …
AstraZeneca announces positive results from phase 3 trial for Tagrisso plus chemotherapy
May 17, 2023Research and Development AstraZeneca, Cancer, Oncology, Tagrisso, chemotherapy
AstraZeneca has announced positive results from the FLAURA2 phase 3 trial which showed that Tagrisso (osimertinib), in combination with chemotherapy, …
RadioMedix and Orano Med complete patient enrolment for neuroendocrine cancer trial
May 16, 2023Medical Communications Oncology, Orano Med, RadioMedix, neuroendocrine cancer, oncology
US-based RadioMedix and French Orano Med, two clinical stage radiopharmaceutical companies, have announced that the last patient has been enrolled …
Astellas and Sony enter collaborative research agreement
May 16, 2023Research and Development ADC, Astellas Pharma, Oncology, Sony, research agreement
Sony and Astellas Pharma have announced that they have entered into a collaborative research agreement in an attempt to discover …
LaNova Medicines and AstraZeneca sign global exclusive license agreement for preclinical ADC
May 15, 2023Research and Development ADC, AstraZeneca, LaNova Medicines, License Agreement, Oncology
Chinese biotechnology company LaNova Medicines and UK-based pharma company AstraZeneca have announced that they have signed a global exclusive license …
Gilead acquires XinThera to strengthen pipeline in oncology and inflammation
May 10, 2023Sales and Marketing Gilead, Oncology, XinThera, inflammation, oncology
Gilead Sciences has announced the acquisition of all outstanding shares of XinThera, a privately-owned biotech company based in San Diego, …
Thermo Fisher and Pfizer collaborate on NGS-based cancer tests
May 10, 2023Medical Communications Cancer, NGS, Oncology, Pfizer, Thermo Fisher Scientifitic, oncology
Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to advance next-generation sequencing (NGS)-based cancer …
Nanobiotix enters final contract negotiations with major pharma company
May 5, 2023Medical Communications FDA, Oncology, nanobiotix, oncology
French late-stage clinical biotechnology company Nanobiotix has announced that it has entered into final contract negotiations with a major pharmaceutical …
Tempus receives FDA Premarket Approval for in vitro diagnostic scan
May 3, 2023Medical Communications Diagnostics, FDA, Oncology, Tempus, in vitro
US-based artificial intelligence (AI) and precision medicine company Tempus has announced that the US Food and Drug Administration (FDA) has …
Latest content
FibroFind appoints Lee Borthwick as CEO
